This IDO1 induction is concomitant with an increase in PD-L1 and PD-L2 and together, may provide the lung cancer cells a survival advantage by Kyn-dependent or PD-L1/2-PD-1-mediated inhibition of T-cell activity (Fig. 6). The gene discussed is IDO1; the disease is lung cancer.